The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review
- PMID: 24524923
- DOI: 10.1016/j.jaut.2014.01.022
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review
Abstract
Multiple sclerosis (MS), is a chronic disease of the central nervous system (CNS) characterized by loss of motor and sensory function, that results from immune-mediated inflammation, demyelination and subsequent axonal damage. MS is one of the most common causes of neurological disability in young adults. Several variants of MS (and CNS demyelinating syndromes in general) have been nowadays defined in an effort to increase the diagnostic accuracy, to identify the unique immunopathogenic profile and to tailor treatment in each individual patient. These include the initial events of demyelination defined as clinically or radiologically isolated syndromes (CIS and RIS respectively), acute disseminated encephalomyelitis (ADEM) and its variants (acute hemorrhagic leukoencephalitis-AHL, Marburg variant, and Balo's concentric sclerosis), Schilder's sclerosis, transverse myelitis, neuromyelitis optica (NMO and NMO spectrum of diseases), recurrent isolated optic neuritis and tumefactive demyelination. The differentiation between them is not only a terminological matter but has important implications on their management. For instance, certain patients with MS and prominent immunopathogenetic involvement of B cells and autoantibodies, or with the neuromyelitic variants of demyelination, may not only not respond well but even deteriorate under some of the first-line treatments for MS. The unique clinical and neuroradiological features, along with the immunological biomarkers help to distinguish these cases from classical MS. The use of such immunological and imaging biomarkers, will not only improve the accuracy of diagnosis but also contribute to the identification of the patients with CIS or RIS who, are at greater risk for disability progression (worse prognosis) or, on the contrary, will have a more benign course. This review summarizes in a critical way, the diagnostic criteria (historical and updated) and the definitions/characteristics of MS of the various variants/subtypes of CNS demyelinating syndromes.
Keywords: Biomarkers; Clinically isolated syndrome (CIS); Diagnostic criteria; Multiple sclerosis (MS); Neuromyelitis optica (NMO); Radiologically isolated syndrome (RIS).
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Idiopathic inflammatory-demyelinating diseases of the central nervous system.Neuroradiology. 2007 May;49(5):393-409. doi: 10.1007/s00234-007-0216-2. Epub 2007 Feb 28. Neuroradiology. 2007. PMID: 17333161 Review.
-
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29. Ann Neurol. 2016. PMID: 26599831
-
Variants of multiple sclerosis.Neuroimaging Clin N Am. 2008 Nov;18(4):703-16, xi. doi: 10.1016/j.nic.2008.06.003. Neuroimaging Clin N Am. 2008. PMID: 19068410 Review.
-
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.Mult Scler. 2012 Aug;18(8):1081-91. doi: 10.1177/1352458511433303. Epub 2012 Jan 17. Mult Scler. 2012. PMID: 22252467
-
Atypical inflammatory demyelinating lesions and atypical multiple sclerosis.Rev Neurol (Paris). 2018 Jun;174(6):408-418. doi: 10.1016/j.neurol.2018.03.007. Epub 2018 Apr 16. Rev Neurol (Paris). 2018. PMID: 29673573 Review.
Cited by
-
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets.J Mol Neurosci. 2024 Oct 28;74(4):101. doi: 10.1007/s12031-024-02269-5. J Mol Neurosci. 2024. PMID: 39466510 Review.
-
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System.Viruses. 2024 Jan 13;16(1):119. doi: 10.3390/v16010119. Viruses. 2024. PMID: 38257819 Free PMC article. Review.
-
Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?AJNR Am J Neuroradiol. 2017 Jan;38(1):12-17. doi: 10.3174/ajnr.A4953. Epub 2016 Oct 6. AJNR Am J Neuroradiol. 2017. PMID: 27758773 Free PMC article.
-
Fulminant multiple sclerosis versus autoimmune encephalitis: A case report.Clin Case Rep. 2024 Feb 9;12(2):e8508. doi: 10.1002/ccr3.8508. eCollection 2024 Feb. Clin Case Rep. 2024. PMID: 38344341 Free PMC article.
-
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.Br J Pharmacol. 2015 Sep;172(17):4277-90. doi: 10.1111/bph.13192. Epub 2015 Jul 14. Br J Pharmacol. 2015. PMID: 25994655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
